# Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male Volunteers

> **NCT01535638** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 207127
- **DRUG:** BI 207127
- **DRUG:** BI 207127

## Key facts

- **NCT ID:** NCT01535638
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-03
- **Final completion:** —
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01535638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01535638, "Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01535638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*